Table 7.
Incorporation of 13C-labeled precursors into rakicidin D
Position | δC | Relative enrichmentsa | |
---|---|---|---|
[2-13C]acetate | [1-13C]-L-serine | ||
1 | 169.2 | 0.89 | 1.58 |
2 | 54.9 | 1.14 | 1.19 |
3 | 72.5 | 1.57 | 1.07 |
4 | 172.7 | 1.31 | 1.95 |
5 | 167.6 | 0.68 | 6.61 |
6 | 52.5 | 0.77 | 1.15 |
7 | 36.5 | 1.00 | 1.00 |
8 | 166.0 | 0.77 | 1.43 |
9 | 118.8 | 3.46 | 1.54 |
10 | 138.4 | 1.03 | 13.97 |
11 | 137.9 | 0.95 | 0.67 |
12 | 117.1 | 1.02 | 1.33 |
13 | 172.5 | 1.61 | 1.26 |
14 | 41.7 | 1.86 | 1.36 |
15 | 78.1 | 1.25 | 1.21 |
16 | 33.9 | 1.91 | 1.39 |
17 | 32.8 | 1.30 | 1.55 |
18 | 27.0 | 2.64 | 1.26 |
19 | 28.9 | 1.15 | 1.58 |
20 | 31.3 | 3.37 | 1.43 |
21 | 22.1 | 1.05 | 1.28 |
22 | 14.0 | 3.37 | 1.61 |
23 | 15.4 | 1.51 | 1.07 |
24 | 13.3 | 1.75 | 1.32 |
a 13C signal intensity of each peak in the labeled 1 divided by that of the corresponding signal in the unlabeled 1, respectively, normalized to give an enrichment ratio of 1 for the unenriched peak of C7. The numbers in bold type indicate 13C-enriched atoms from 13C-labeled precursors